OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
David Schwicker, MA, Principal, ORPHA Strategy Consulting, Basle, Switzerland.
Highlights of last year's ISPOR European Congress panel debated on one of the key issues regarding patient access to transformative treatments: adaptive pathways and the application of real-world evidence.